ออฟไลน์ด้วยแอป Player FM !
Treating Severe Respiratory Failure in COVID-19 Patients with Dr. Jonathan Javitt NeuroRx
Manage episode 282622625 series 99915
Dr. Jonathan Javitt, Founder, Chairman and CEO, NeuroRx talks about drawing on their work developing novel therapeutics for bipolar depression and respiratory disease to focus on a therapy, aviptadil also known as ZYESAMI, for critical COVID-19 especially those with advanced comorbidities. This peptide hormone VIP enters the alveolar type II rare cell in the lung and blocks the replication of the SARs-CoV-2 virus and the production of inflammatory cytokines. Available through the FDA Expanded Access protocol, this drug is showing a nine-fold difference in survival and recovery from respiratory failure compared to patients with best available standard of care.
@neurorxpharma #aviptadil #RLF-100 #ZYESAMI #coronavirus #COVID19 #drugdevelopment #pandemic $NRXP
1725 ตอน
Manage episode 282622625 series 99915
Dr. Jonathan Javitt, Founder, Chairman and CEO, NeuroRx talks about drawing on their work developing novel therapeutics for bipolar depression and respiratory disease to focus on a therapy, aviptadil also known as ZYESAMI, for critical COVID-19 especially those with advanced comorbidities. This peptide hormone VIP enters the alveolar type II rare cell in the lung and blocks the replication of the SARs-CoV-2 virus and the production of inflammatory cytokines. Available through the FDA Expanded Access protocol, this drug is showing a nine-fold difference in survival and recovery from respiratory failure compared to patients with best available standard of care.
@neurorxpharma #aviptadil #RLF-100 #ZYESAMI #coronavirus #COVID19 #drugdevelopment #pandemic $NRXP
1725 ตอน
All episodes
×ขอต้อนรับสู่ Player FM!
Player FM กำลังหาเว็บ